PACOR, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 12.166
EU - Europa 7.715
AS - Asia 5.654
SA - Sud America 648
AF - Africa 173
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 12
Totale 26.386
Nazione #
US - Stati Uniti d'America 11.993
SG - Singapore 2.070
PL - Polonia 1.835
CN - Cina 1.468
IT - Italia 1.065
SE - Svezia 993
DE - Germania 951
UA - Ucraina 714
VN - Vietnam 560
BR - Brasile 511
HK - Hong Kong 491
RU - Federazione Russa 404
GB - Regno Unito 373
FR - Francia 334
KR - Corea 327
FI - Finlandia 322
TR - Turchia 237
NL - Olanda 150
BG - Bulgaria 125
IE - Irlanda 124
BD - Bangladesh 122
IN - India 98
CA - Canada 87
CH - Svizzera 54
MA - Marocco 54
BE - Belgio 53
MX - Messico 49
AR - Argentina 47
BY - Bielorussia 43
JP - Giappone 43
ES - Italia 39
ZA - Sudafrica 38
IQ - Iraq 32
AT - Austria 27
PK - Pakistan 26
ID - Indonesia 23
UZ - Uzbekistan 19
VE - Venezuela 19
KE - Kenya 18
SN - Senegal 18
PH - Filippine 17
RO - Romania 17
CO - Colombia 16
EC - Ecuador 16
AU - Australia 14
BA - Bosnia-Erzegovina 14
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
PE - Perù 11
TH - Thailandia 11
EG - Egitto 10
JO - Giordania 10
LT - Lituania 10
PT - Portogallo 10
HR - Croazia 9
MY - Malesia 9
EU - Europa 8
IL - Israele 8
IR - Iran 8
KZ - Kazakistan 8
RS - Serbia 8
SA - Arabia Saudita 8
HU - Ungheria 7
PY - Paraguay 7
HN - Honduras 6
OM - Oman 6
UY - Uruguay 6
DZ - Algeria 5
GA - Gabon 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CI - Costa d'Avorio 3
GR - Grecia 3
LV - Lettonia 3
NO - Norvegia 3
PR - Porto Rico 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DM - Dominica 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
MN - Mongolia 2
Totale 26.355
Città #
Warsaw 1.693
Singapore 1.242
Ann Arbor 1.188
Ashburn 1.136
Woodbridge 1.067
Houston 864
Fairfield 856
Chandler 700
San Jose 628
Jacksonville 621
Hong Kong 480
Wilmington 459
Dallas 454
Hefei 424
Seattle 365
Beijing 345
Trieste 334
Seoul 322
Cambridge 281
Princeton 229
Boardman 227
Izmir 194
Chicago 176
Los Angeles 164
Ho Chi Minh City 163
Columbus 134
Hanoi 130
Sofia 125
Dublin 122
Lauterbourg 121
Dearborn 120
Zgierz 116
The Dalles 115
Moscow 107
Santa Clara 93
Helsinki 91
Buffalo 89
Milan 83
Frankfurt am Main 81
New York 74
Council Bluffs 73
London 73
Düsseldorf 69
San Diego 58
Munich 56
Amsterdam 51
São Paulo 50
Brussels 48
Casablanca 44
Guangzhou 39
Bern 37
Tokyo 35
Phoenix 34
Porto Alegre 34
Falls Church 33
Orem 33
Shanghai 32
North Bergen 29
Brooklyn 28
Da Nang 28
Atlanta 27
Bremen 25
Haiphong 25
Mestre 25
Redwood City 25
Stockholm 23
Montreal 22
Denver 21
Des Moines 21
Norwalk 21
Rio de Janeiro 21
Tianjin 21
Turku 21
Verona 21
Kunming 20
Nanjing 20
Nuremberg 20
Johannesburg 19
Miano 19
Rome 19
Washington 19
Dakar 18
Dong Ket 18
Toronto 18
Sacile 17
Tashkent 17
Vienna 17
Grafing 16
Jinan 16
Ottawa 16
Mexico City 15
Nairobi 15
Roubaix 15
Wroclaw 15
Chennai 14
Paris 14
Redmond 14
Redondo Beach 14
San Francisco 14
Baghdad 13
Totale 17.848
Nome #
[1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines 618
Arabica coffee extract shows antibacterial activity against Staphylococcus epidermidis and Enterococcus faecalis and low toxicity towards a human cell line 526
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 519
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 472
Effects of gold nanoparticles, protected by self-assembling mixtures of ligands, on eukaryotic cells and model membranes 462
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine 409
HIV Protease Inhibitors Apoptotic Effect in SH-SY5Y Neuronal Cell Line 399
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 383
Insights on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 374
Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives 368
Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing 343
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 324
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 312
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. 309
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. 293
Mixed Fluorinated/Hydrogenated Self-Assembled Monolayer-Protected Gold Nanoparticles: In Silico and In Vitro Behavior 287
Apoptotic pathways of U937 leukemic monocytes investigated by infrared microspectroscopy and flow cytometry 278
Antifungal Activity of Amphotericin BConjugated to Carbon Nanotubes 267
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852) 252
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): Toward a powerful label-free cell-based assay 245
Primate beta-defensins--structure, function and evolution. 244
The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage 243
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 242
Optimization of microfluidic systems for IRMS long term measurement of living cells 242
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 242
Dual mode of action of Bac7, a proline-rich antibacterial peptide 241
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 241
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 240
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 240
Structure dependence of biological activities for primate cathelicidins. 239
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37 238
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 237
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 234
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 234
Multivalent, mixed self-assembled monolayer protected gold nanoparticles: from design to biological application 234
Synthetic antimicrobial peptides designed from sequence templates 233
Photobiomodulation therapy promotes in vitro wound healing in nicastrin KO HaCaT cells 233
Ruthenium(III) complexes as antineoplastic agents. 228
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 227
Galectin-1 in cartilage: expression and influence on chondrocytes growth and interaction with ECM components 226
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 225
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 225
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 223
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 223
Computational and experimental investigation on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 219
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 218
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 213
Primate cathelicidin orthologues display different structures and membrane interactions 213
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 212
Rapid and reliable detection of antimicrobial peptide penetration into Gram-negative bacteria based on fluorescence quenching. 211
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 210
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity 208
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 208
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 206
Mast cell activation by myelin through scavenger receptor. 203
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 199
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 199
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 198
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 197
Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2 196
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 195
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 195
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 194
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 193
Fabrication of a microfluidic platform for investigating dynamic biochemical processes in living samples by FTIR microspectroscopy 193
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 190
Bacillus cereus cell and spore properties as influenced by the micro-structure of the medium 189
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 188
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 187
Biological and technological evaluation of PVC containers for human blood and blood components 185
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 185
Synchrotron radiation infrared microspectroscopy of single living cells in microfluidic devices: Advantages, disadvantages and future perspectives 185
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data 185
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma 183
DON'T JUDGE A BOOK BY ITS COVER: JANUS AND STRIPED SAM-PROTECTED GOLD NANOPARTICLES AT THE NANO-BIO INTERFACE 183
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 181
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 177
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 177
Tumour metastatic potential after treatment with selective antimetastatic drugs 176
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 176
Artificial beta-defensin based on a minimal defensin template 174
Cytofluorimetric analysis of gut-intraepitelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme 173
Lysozyme induced recovery of the response to ConA on mononuclear cells harvested from mice bearing MCa mammary carcinoma 172
Recovery of lymphocyte CD4+:CD8+ ratio in patients treated with lysozyme 168
Structure-activity relationship study on Bac7(1-35), a synthetic fragment of the Pro-rich antibacterial peptide Bac7 163
Hydrogels based on methylated-alginates as a platform to investigate the effect of material properties on cell activity. The role of material compliance 162
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 160
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. 160
Modification of growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides 160
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 157
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 156
Infrared microspectroscopy of biochemical response of living cells in microfabricated devices 155
Mechanism of tumor inhibition by the metal complex trans-RuCl2(dimethylsulphoxide)4 154
Water soluble ruthenium(III)-dimethyl sulfoxide complexes: chemical behaviour and pharmacological properties 152
Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides 151
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph nodelymphocytes of tumour bearing mice fed with egg-white lysozyme. 148
Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice 147
Influence of agar content on the growth parameters of Bacillus cereus. 143
Effects of the Ru(III) complexes mer-RuCl3(DMSO)2Im and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors. 142
Intra-tumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and TIL recruitment. 140
Totale 23.238
Categoria #
all - tutte 71.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.673 56 113 123 230 32 137 80 50 172 188 108 384
2022/20232.081 210 287 161 314 188 363 7 179 215 20 78 59
2023/20241.084 97 70 73 71 108 71 163 221 22 29 91 68
2024/20253.079 49 117 196 282 276 288 272 168 390 361 304 376
2025/20267.761 705 608 801 653 647 674 1.118 244 766 950 359 236
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 26.873